Twist Bioscience Corp TWST
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 66.30M
- Market Cap
- €178.58B
- Volume/Avg
- 6,439 / 6,439
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company’s proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 979
- Website
- https://www.twistbioscience.com
Valuation
|
Metric
|
TWST
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
TWST
|
|---|---|
Quick Ratio | 2.12 |
Current Ratio | 2.67 |
Interest Coverage | — |
Quick Ratio
TWST
Profitability
|
Metric
|
TWST
|
|---|---|
Return on Assets (Normalized) | −12.00% |
Return on Equity (Normalized) | −17.01% |
Return on Invested Capital (Normalized) | −15.43% |
Return on Assets
TWST
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|M&L@>!M | LOCK|Q#hK^ | $129B | |||
| Moderna Inc
MRNA
| LOCK|ksw<t$F | LOCK|@T! | $90B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|CP>SL< | LOCK|>B@v | $77B | |||
| argenx SE ADR
ARGX
| LOCK|s@ls^V | LOCK|SH# | $51B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|>&#$F> | LOCK|f> | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|Z$<!d? | LOCK|$FsfW | $31B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|R^Cx#m% | LOCK|&H#D | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|K$YmWms | LOCK|h&g | $24B | |||
| Incyte Corp
INCY
| LOCK|KQl^!Nw | LOCK|$h | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|@>R@&n | LOCK|zp | $14B |
United States